Pelizaeus-merzbacher disease, pelizaeus-merzbacher-like disease 1, and related hypomyelinating disorders

Seminars in Neurology

Volumn 32, Issue 1, 2012, Pages 62-67

  Hobson, Grace M ^a,c   Garbern, James Y ^b  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Pelizaeus Merzbacher disease; Pelizaeus Merzbacher like disease; spastic paraplegia 2; spastic paraplegia 44

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; CARBAMAZEPINE; DIAZEPAM; GAP JUNCTION PROTEIN; PROTEOLIPID PROTEIN; TIZANIDINE;

ARTICLE; ATAXIA; CHOREOATHETOSIS; COGNITIVE DEFECT; COMMUNICATION AID; COPY NUMBER VARIATION; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EVOKED BRAIN STEM AUDITORY RESPONSE; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC SCREENING; LEUKODYSTROPHY; LIMB WEAKNESS; MOLECULAR DIAGNOSIS; MUSCLE HYPOTONIA; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NYSTAGMUS; ORTHOTICS; PELIZAEUS MERZBACHER DISEASE; PHYSIOTHERAPY; POINT MUTATION; PREIMPLANTATION EMBRYO; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCOLIOSIS; SEIZURE; SPASTIC PARAPLEGIA; SPASTICITY; SPECIAL EDUCATION; TREMOR;

DEMYELINATING DISEASES; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MUTATION; PARAPLEGIA; PELIZAEUS-MERZBACHER DISEASE;

EID: 84858146268     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0032-1306388     Document Type: Article

References (54)

1. Mimault C, Giraud G, Courtois V., et al. The Clinical European Network on Brain Dysmyelinating Disease. Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. Am J Hum Genet: 1999; 65 2 360 369 (Pubitemid 30462994)
2. Woodward KJ, Cundall M, Sperle K., et al. Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination. Am J Hum Genet: 2005; 77 6 966 987 (Pubitemid 41698518)
3. Lee JA, Inoue K, Cheung SW, Shaw CA, Stankiewicz P, Lupski JR. Role of genomic architecture in PLP1 duplication causing Pelizaeus-Merzbacher disease. Hum Mol Genet: 2006; 15 14 2250 2265 (Pubitemid 43985516)
4. Regis S, Biancheri R, Bertini E., et al. Genotype-phenotype correlation in five Pelizaeus-Merzbacher disease patients with PLP1 gene duplications. Clin Genet: 2008; 73 3 279 287 (Pubitemid 351228516)
5. Shimojima K, Inoue T, Hoshino A., et al. Comprehensive genetic analyses of PLP1 in patients with Pelizaeus-Merzbacher disease applied by array-CGH and fiber-FISH analyses identified new mutations and variable sizes of duplications. Brain Dev: 2010; 32 3 171 179
6. Hodes ME, Woodward K, Spinner NB., et al. Additional copies of the proteolipid protein gene causing Pelizaeus-Merzbacher disease arise by separate integration into the X chromosome. Am J Hum Genet: 2000; 67 1 14 22 (Pubitemid 30481540)
7. Inoue K, Osaka H, Thurston VC., et al. Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet: 2002; 71 4 838 853 (Pubitemid 135750516)
8. Shy ME, Hobson G, Jain M., et al. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol: 2003; 53 3 354 365 (Pubitemid 36258639)
9. Hobson GM, Huang Z, Sperle K., et al. Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes. Hum Mutat: 2006; 27 1 69 77 (Pubitemid 43042968)
10. Bonnet-Dupeyron MN, Combes P, Santander P, Cailloux F, Boespflug-Tanguy O, Vaurs-Barrire C. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations. Hum Mutat: 2008; 29 8 1028 1036
11. Grossi S, Regis S, Biancheri R., et al. Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations. Orphanet J Rare Dis: 2011; 6 40
12. Wolf NI, Sistermans EA, Cundall M., et al. Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. Brain: 2005; 128 Pt 4 743 751 (Pubitemid 40516913)
13. Combes P, Bonnet-Dupeyron MN, Gauthier-Barichard F., et al. PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1. Neurogenetics: 2006; 7 1 31 37 (Pubitemid 43327682)
14. Garbern J, Krajewski K. Hobson G, PLP1-related disorders. In: Pagon R, Bird T, Dolan C, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993; http://www.ncbi.nlm.nih.gov/books/NBK1182/. Accessed September 29, 2011
15. Heim P, Claussen M, Hoffmann B., et al. Leukodystrophy incidence in Germany. Am J Med Genet: 1997; 71 4 475 478 (Pubitemid 27371851)
16. Seeman P, Krsck P, Namestkova K., et al. Pelizaeus-Merzbacher's disease (PMD) - Detection of the most frequent mutation of the proteolipid protein gene in Czech patients and families with the classical form of PMD. Ceska Slovenska Neurol Neurochir: 2003; 66 95 104 (Pubitemid 36417158)
17. Abrams CK, Scherer SS. Gap junctions in inherited human disorders of the central nervous system. Biochim Biophys Acta: 2011
18. Uhlenberg B, Schuelke M, Rüschendorf F., et al. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet: 2004; 75 2 251 260 (Pubitemid 38943868)
19. Salviati L, Trevisson E, Baldoin MC., et al. A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics: 2007; 8 1 57 60 (Pubitemid 44951520)
20. Wolf NI, Cundall M, Rutland P., et al. Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics: 2007; 8 1 39 44 (Pubitemid 44951517)
21. Bugiani M, Al Shahwan S, Lamantea E., et al. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology: 2006; 67 2 273 279 (Pubitemid 44305412)
22. Henneke M, Combes P, Diekmann S., et al. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology: 2008; 70 10 748 754
23. Wang J, Wang H, Wang Y, Chen T, Wu X, Jiang Y. Two novel gap junction protein alpha 12 gene mutations in two Chinese patients with Pelizaeus-Merzbacher-like disease. Brain Dev: 2010; 32 3 236 243
24. Combes P, Kammoun N, Monnier A., et al. Relevance of GJC2 promoter mutation in Pelizaeus-Merzbacher-like disease. Ann Neurol: 2010; 71 1 146 148
25. Orthmann-Murphy JL, Salsano E, Abrams CK., et al. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain: 2009; 132 Pt 2 426 438
26. Ferrell RE, Baty CJ, Kimak MA., et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet: 2010; 86 6 943 948
27. Boulloche J, Aicardi J. Pelizaeus-Merzbacher disease: clinical and nosological study. J Child Neurol: 1986; 1 3 233 239 (Pubitemid 17171109)
28. Hodes ME, Pratt VM, Dlouhy SR. Genetics of Pelizaeus-Merzbacher disease. Dev Neurosci: 1993; 15 6 383 394 (Pubitemid 24296435)
29. Cailloux F, Gauthier-Barichard F, Mimault C., et al. Clinical European Network on Brain Dysmyelinating Disease. Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Eur J Hum Genet: 2000; 8 11 837 845
30. Garbern JY, Yool DA, Moore GJ., et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain: 2002; 125 Pt 3 551 561 (Pubitemid 34194410)
31. Sistermans EA, de Coo RF, De Wijs IJ, Van Oost BA. Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease. Neurology: 1998; 50 6 1749 1754 (Pubitemid 28283246)
32. Fattal-Valevski A, DiMaio MS, Hisama FM., et al. Variable expression of a novel PLP1 mutation in members of a family with Pelizaeus-Merzbacher disease. J Child Neurol: 2009; 24 5 618 624
33. Hurst S, Garbern J, Trepanier A, Gow A. Quantifying the carrier female phenotype in Pelizaeus-Merzbacher disease. Genet Med: 2006; 8 6 371 378 (Pubitemid 44297308)
34. Carvalho C, Bartnik M, Pehlivan D., et al. Evidence for disease penetrance relating to CNV size: Pelizaeus-Merzbacher disease and manifesting carriers with a familial 11 Mb duplication at Xq22. Clin Genet, in press
35. Nezu A, Kimura S, Takeshita S, Osaka H, Kimura K, Inoue K. An MRI and MRS study of Pelizaeus-Merzbacher disease. Pediatr Neurol: 1998; 18 4 334 337 (Pubitemid 28191528)
36. Plecko B, Stöckler-Ipsiroglu S, Gruber S., et al. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype. Neuropediatrics: 2003; 34 3 127 136 (Pubitemid 36994401)
37. Steenweg ME, Vanderver A, Blaser S., et al. Magnetic resonance imaging pattern recognition in hypomyelinating disorders. Brain: 2010; 133 10 2971 2982
38. Barkovich AJ. Magnetic resonance techniques in the assessment of myelin and myelination. J Inherit Metab Dis: 2005; 28 3 311 343 (Pubitemid 40723867)
39. Takanashi J, Inoue K, Tomita M., et al. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication. Neurology: 2002; 58 2 237 241 (Pubitemid 34084213)
40. Bonavita S, Schiffmann R, Moore DF., et al. Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology: 2001; 56 6 785 788 (Pubitemid 32240103)
41. Hobson GM, Huang Z, Sperle K, Stabley DL, Marks HG, Cambi F. A PLP splicing abnormality is associated with an unusual presentation of PMD. Ann Neurol: 2002; 52 4 477 488
42. Hanefeld FA, Brockmann K, Pouwels PJ, Wilken B, Frahm J, Dechent P. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination. Neurology: 2005; 65 5 701 706 (Pubitemid 41285848)
43. Henneke M, Gegner S, Hahn A., et al. Clinical neurophysiology in GJA12-related hypomyelination vs Pelizaeus-Merzbacher disease. Neurology: 2010; 74 22 1785 1789
44. Verlinsky Y, Rechitsky S, Laziuk K, Librach C, Genovese R, Kuliev A. Preimplantation genetic diagnosis for Pelizaeus-Merzbacher disease with testing for age-related aneuploidies. Reprod Biomed Online: 2006; 12 1 83 88 (Pubitemid 43109362)
45. Welch KO, Marin RS, Pandya A, Arnos KS. Compound heterozygosity for dominant and recessive GJB2 mutations: effect on phenotype and review of the literature. Am J Med Genet A: 2007; 143A 14 1567 1573 (Pubitemid 47047780)
46. Feinstein M, Markus B, Noyman I., et al. Pelizaeus-Merzbacher-like disease caused by AIMP1/p43 homozygous mutation. Am J Hum Genet: 2010; 87 6 820 828
47. Magen D, Georgopoulos C, Bross P., et al. Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy. Am J Hum Genet: 2008; 83 1 30 42
48. Biancheri R, Zara F, Bruno C., et al. Hypomyelination and congenital cataract. In: Pagon R, Bird T, Dolan C, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993; http://www.ncbi.nlm.nih.gov/books/NBK2587/. Accessed September 29, 2011
49. Dempsey MA, Dumitrescu AM. Refetoff S, MCT8 (SLC16A2)-specific thyroid hormone cell transporter deficiency. In: Pagon R, Bird T, Dolan C, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993; http://www.ncbi.nlm. nih.gov/books/NBK26373/. Accessed September 29, 2011
50. Padiath QS, Saigoh K, Schiffmann R., et al. Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet: 2006; 38 10 1114 1123 (Pubitemid 44470356)
51. Adams D, Gahl WA. Free sialic acid storage disorders. In: Pagon R, Bird T, Dolan C, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993; http://www.ncbi.nlm.nih.gov/books/NBK1470/. Accessed September 29, 2011
52. Inoue K, Khajavi M, Ohyama T., et al. Molecular mechanism for distinct neurological phenotypes conveyed by allelic truncating mutations. Nat Genet: 2004; 36 4 361 369 (Pubitemid 38437258)
53. Schrander-Stumpel C, Vos YJ. L1 Syndrome. In: Pagon R, Bird T, Dolan C, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993; http://www.ncbi.nlm.nih.gov/books/NBK1484/. Accessed September 29, 2011
54. Fink JK. Hereditary spastic paraplegia overview. In: Pagon R, Bird T, Dolan C, Stephens K., eds. GeneReviews. Seattle University of Washington: 1993; http://www.ncbi.nlm.nih.gov/books/NBK1509/. Accessed September 29, 2011